Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 2 |
Hewlett Packard
HPE
|
+$69.4M |
| 3 |
ExxonMobil
XOM
|
+$63.8M |
| 4 |
Synchrony
SYF
|
+$52.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$52.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$518M |
| 2 |
HP
HPQ
|
+$112M |
| 3 |
CSC
Computer Sciences
CSC
|
+$88.4M |
| 4 |
Archer Daniels Midland
ADM
|
+$57.5M |
| 5 |
General Dynamics
GD
|
+$52.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 13.97% |
| 3 | Technology | 13.36% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
First Financial Bancorp
FFBC
$3.56B
| $5.17M | 0.01% |
285,825
+12,065
| +4% | +$232K |
|
1502
Dorman Products
DORM
$3.92B
| $5.16M | 0.01% |
108,692
+5,907
| +6% | +$288K |
|
1503
Celldex Therapeutics
CLDX
$3.5B
| $5.16M | 0.01% |
21,916
+1,187
| +6% | +$259K |
|
1504
CONMED
CNMD
$1.46B
| $5.15M | 0.01% |
116,855
+7,726
| +7% | +$335K |
|
|
KYNB
1505
Kyntra Bio
KYNB
$28.9M
| $5.15M | 0.01% |
6,755
+1,127
| +20% | +$748K |
|
1506
Amkor Technology
AMKR
$14.1B
| $5.14M | 0.01% |
846,147
+11,274
| +1% | +$68.3K |
|
1507
Green Plains
GPRE
$1.07B
| $5.13M | 0.01% |
224,007
+41,494
| +23% | +$880K |
|
|
ITCI
1508
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.12M | 0.01% |
95,128
+30,279
| +47% | +$1.53M |
|
1509
ArcBest
ARCB
$3.1B
| $5.11M | 0.01% |
238,773
+3,948
| +2% | +$97.5K |
|
|
MEG
1510
DELISTED
Media General, Inc
MEG
| $5.08M | 0.01% |
314,374
+41,042
| +15% | +$619K |
|
1511
News Corp Class B
NWS
$17.5B
| $5.05M | 0.01% |
361,819
+57,545
| +19% | +$825K |
|
1512
AMN Healthcare
AMN
$1.26B
| $5.03M | 0.01% |
162,114
+4,978
| +3% | +$147K |
|
1513
Usana Health Sciences
USNA
$254M
| $5.03M | 0.01% |
78,782
-14,694
| -16% | -$953K |
|
|
SYNH
1514
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.03M | 0.01% |
103,743
+18,520
| +22% | +$824K |
|
|
UTIW
1515
DELISTED
UTI WORLDWIDE INC
UTIW
| $5.03M | 0.01% |
715,360
+104,501
| +17% | +$709K |
|
1516
Methode Electronics
MEI
$604M
| $5M | 0.01% |
156,989
-6,922
| -4% | -$233K |
|
|
DENN
1517
DELISTED
Denny's
DENN
| $4.99M | 0.01% |
507,797
+220,898
| +77% | +$2.27M |
|
|
ZEN
1518
DELISTED
ZENDESK INC
ZEN
| $4.99M | 0.01% |
188,574
+33,216
| +21% | +$779K |
|
1519
Westamerica Bancorp
WABC
$1.37B
| $4.98M | 0.01% |
106,588
+3,632
| +4% | +$169K |
|
1520
BOK Financial
BOKF
$8.76B
| $4.98M | 0.01% |
83,280
+19,921
| +31% | +$1.3M |
|
1521
Smith & Wesson
SWBI
$637M
| $4.97M | 0.01% |
294,207
+27,777
| +10% | +$409K |
|
1522
Thomson Reuters
TRI
$44B
| $4.96M | 0.01% |
112,997
-4,109
| -4% | -$191K |
|
1523
Adtran
ADTN
$665M
| $4.95M | 0.01% |
287,350
+22,594
| +9% | +$360K |
|
1524
State Street SPDR Dow Jones REIT ETF
RWR
$1.86B
| $4.95M | 0.01% |
54,000
+4,000
| +8% | +$362K |
|
1525
FirstCash
FCFS
$9.12B
| $4.94M | 0.01% |
132,072
+24,443
| +23% | +$953K |
|
Similar funds
Charles Schwab's Q4 2015 Portfolio in Review
As of Q4 2015, Charles Schwab held 3,154 positions worth $74.3B, up 9.5% from $67.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $2.73B of net new capital in Q4 2015, opening 61 new positions and adding to 2,298 existing holdings. Its largest new stake was Alphabet (Google) Class A: 16,017,840 shares worth $623M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $518M trimmed.
- Charles Schwab's largest Q4 2015 buy was Alphabet (Google) Class A: 16,017,840 shares worth $623M.
- Charles Schwab added most to ExxonMobil in Q4 2015, an estimated $63.8M increase.
- Charles Schwab's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $518M.
- Charles Schwab fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $42.3M.
- Charles Schwab's ten largest holdings make up 14% of its $74.3B portfolio in Q4 2015.
- Charles Schwab opened 61 new positions and closed 53 in Q4 2015.
- Charles Schwab's portfolio value rose 9.5% quarter-over-quarter to $74.3B.
Based on Charles Schwab's 13F filing for Q4 2015, filed 11 Feb 2016.